Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 11Warts 2Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2HIV Infections 2Condylomata Acuminata 2Acquired Immunodeficiency Syndrome 2Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Infections 1Human Papillomavirus-Related Cervical Carcinoma 1Human Papillomavirus-Related Carcinoma 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1Cancer Survivor 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Vaccines, Synthetic 10Papillomavirus Vaccines 6Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1PRA1 protein, Candida albicans 1Omiganan 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Condylomata Acuminata × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT06681636 2024-11-08

HPV9vxFSW

National Institute of Hygiene and Epidemiology, Vietnam

Phase 2 Not yet recruiting
300 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡